구강용 살균 소독제 시장 규모 : 화학 조성, 형태, 유통 채널, 용도 및 지역별(2026-2034년)

The global oral antiseptics market size reached USD 2.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.9 Billion by 2034, exhibiting a growth rate (CAGR) of 3.96% during 2026-2034. The introduction of oral antiseptics, extensive research and development (R&D) activities, and the rising awareness regarding oral care represent some of the key factors driving the market.

Oral antiseptics are medical agents that stop or slow down the growth of microorganisms. They are primarily liquid products with various chemical compositions used to rinse the teeth, gums, and mouth. They usually contain an antiseptic to kill harmful bacteria that can live between the teeth and tongue. Oral antiseptics are widely available in solution and gel variants and are used to help with mouth infections, ulcers, and gum disease. They assist in relieving minor mouth irritation, such as canker or cold sores, gingivitis, dentures, and orthodontic appliances. Oral antiseptics easily reach inaccessible mouth areas that are difficult to clean with a toothbrush and help in preventing caries, plaque formation, and potential infections by pathogens.

Oral Antiseptics Market Trends:

The rising awareness regarding oral care across the globe is one of the key factors driving the market growth. Oral antiseptics help prevent cavities, gum diseases, bad breath tooth decay, and control plaque from building up by disrupting the bacterial load in the mouth. In line with this, the increasing prevalence of oral and dental disorders due to the changing dietary patterns of the masses and the rising consumption of processed food products is favoring the market growth. Moreover, the widespread product utilization in oral surgery and dental care regimens, such as harvesting bone chips, irrigation of extraction sockets, and sterilization of osteonecrotic bone, is acting as another growth-inducing factor. Apart from this, the introduction of oral antiseptics manufactured with various essential oils, including eucalyptus, peppermint, and thyme oil, that also act as a breath refresher is providing an impetus to the market growth. Additionally, the widespread adoption of natural and organic oral care products that act as mild antiseptics used in the mouth to disinfect surfaces or clean minor cuts is positively influencing the market growth. Furthermore, the widespread product adoption among adolescents and adults suffering from excessive plaque and dental cavities due to the increasing consumption of tobacco, alcohol, and sugary food and beverages is propelling the market growth. Other factors, including easy product availability across e-commerce platforms, escalating growth in the healthcare industry, widespread utilization of non-alcoholic oral antiseptics in animals, rising expenditure capacities of consumers, extensive research and development (R&D) activities, and the implementation of various government initiatives to promote oral hygiene are anticipated to drive the market growth further.

Key Market Segmentation:

This report provides an analysis of the key trends in each segment of the global oral antiseptics market, along with forecasts at the global, regional, and country level from 2026-2034. The report has categorized the market based on chemical composition, form, distribution channel, and application.

Chemical Composition Insights:

• Chlorhexidine Gluconate
• Cetylpyridinium Chloride
• Herbal and Essential Oil
• Others

Form Insights:

• Solution
• Gel

Distribution Channel Insights:

• Drug Stores
• Retail Pharmacies
• Online Stores
• Supermarkets and Hypermarkets
• Others

Application Insights:

• Dental Care
• Oral Cleaning
• Others

Regional Insights:

• North America
• United States
• Canada
• Asia Pacific
• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Spain
• Russia
• Others
• Latin America
• Brazil
• Mexico
• Others
• Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for oral antiseptics. Some of the factors driving the North America oral antiseptics market included rising awareness regarding oral care, escalating growth in the healthcare industry, and the increasing prevalence of oral and dental disorders.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global oral antiseptics market. Detailed profiles of all major companies have also been provided. Some of the companies covered include 3M Company, Agrawal Drugs Pvt. Ltd., Church & Dwight Co. Inc., Colgate-Palmolive Company, Dentaid SL, ICM Pharma Pte. Ltd., ICPA Health Products Ltd., Johnson & Johnson, Luxica Pharma Inc., Procter & Gamble Company, Purdue Pharma L.P., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report

1. How big is the global oral antiseptics market?

2. What is the expected growth rate of the global oral antiseptics market during 2026-2034?

3. What are the key factors driving the global oral antiseptics market?

4. What has been the impact of COVID-19 on the global oral antiseptics market?

5. What is the breakup of the global oral antiseptics market based on the chemical composition?

6. What is the breakup of the global oral antiseptics market based on the form?

7. What is the breakup of the global oral antiseptics market based on the distribution channel?

8. What is the breakup of the global oral antiseptics market based on the application?

9. What are the key regions in the global oral antiseptics market?

10. Who are the key players/companies in the global oral antiseptics market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Oral Antiseptics Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Chemical Composition

• 6.1 Chlorhexidine Gluconate
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Cetylpyridinium Chloride
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Herbal and Essential Oil
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Others
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast

7 Market Breakup by Form

• 7.1 Solution
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Gel
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

• 8.1 Drug Stores
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Retail Pharmacies
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Online Stores
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Supermarkets and Hypermarkets
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast
• 8.5 Others
  • 8.5.1 Market Trends
  • 8.5.2 Market Forecast

9 Market Breakup by Application

• 9.1 Dental Care
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Oral Cleaning
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Others
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 United States
    • 10.1.1.1 Market Trends
    • 10.1.1.2 Market Forecast
  • 10.1.2 Canada
    • 10.1.2.1 Market Trends
    • 10.1.2.2 Market Forecast
• 10.2 Asia-Pacific
  • 10.2.1 China
    • 10.2.1.1 Market Trends
    • 10.2.1.2 Market Forecast
  • 10.2.2 Japan
    • 10.2.2.1 Market Trends
    • 10.2.2.2 Market Forecast
  • 10.2.3 India
    • 10.2.3.1 Market Trends
    • 10.2.3.2 Market Forecast
  • 10.2.4 South Korea
    • 10.2.4.1 Market Trends
    • 10.2.4.2 Market Forecast
  • 10.2.5 Australia
    • 10.2.5.1 Market Trends
    • 10.2.5.2 Market Forecast
  • 10.2.6 Indonesia
    • 10.2.6.1 Market Trends
    • 10.2.6.2 Market Forecast
  • 10.2.7 Others
    • 10.2.7.1 Market Trends
    • 10.2.7.2 Market Forecast
• 10.3 Europe
  • 10.3.1 Germany
    • 10.3.1.1 Market Trends
    • 10.3.1.2 Market Forecast
  • 10.3.2 France
    • 10.3.2.1 Market Trends
    • 10.3.2.2 Market Forecast
  • 10.3.3 United Kingdom
    • 10.3.3.1 Market Trends
    • 10.3.3.2 Market Forecast
  • 10.3.4 Italy
    • 10.3.4.1 Market Trends
    • 10.3.4.2 Market Forecast
  • 10.3.5 Spain
    • 10.3.5.1 Market Trends
    • 10.3.5.2 Market Forecast
  • 10.3.6 Russia
    • 10.3.6.1 Market Trends
    • 10.3.6.2 Market Forecast
  • 10.3.7 Others
    • 10.3.7.1 Market Trends
    • 10.3.7.2 Market Forecast
• 10.4 Latin America
  • 10.4.1 Brazil
    • 10.4.1.1 Market Trends
    • 10.4.1.2 Market Forecast
  • 10.4.2 Mexico
    • 10.4.2.1 Market Trends
    • 10.4.2.2 Market Forecast
  • 10.4.3 Others
    • 10.4.3.1 Market Trends
    • 10.4.3.2 Market Forecast
• 10.5 Middle East and Africa
  • 10.5.1 Market Trends
  • 10.5.2 Market Breakup by Country
  • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

• 11.1 Overview
• 11.2 Drivers
• 11.3 Restraints
• 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 3M Company
    • 15.3.1.1 Company Overview
    • 15.3.1.2 Product Portfolio
    • 15.3.1.3 Financials
    • 15.3.1.4 SWOT Analysis
  • 15.3.2 Agrawal Drugs Pvt. Ltd.
    • 15.3.2.1 Company Overview
    • 15.3.2.2 Product Portfolio
  • 15.3.3 Church & Dwight Co. Inc.
    • 15.3.3.1 Company Overview
    • 15.3.3.2 Product Portfolio
    • 15.3.3.3 Financials
    • 15.3.3.4 SWOT Analysis
  • 15.3.4 Colgate-Palmolive Company
    • 15.3.4.1 Company Overview
    • 15.3.4.2 Product Portfolio
    • 15.3.4.3 Financials
    • 15.3.4.4 SWOT Analysis
  • 15.3.5 Dentaid SL
    • 15.3.5.1 Company Overview
    • 15.3.5.2 Product Portfolio
  • 15.3.6 ICM Pharma Pte. Ltd.
    • 15.3.6.1 Company Overview
    • 15.3.6.2 Product Portfolio
  • 15.3.7 ICPA Health Products Ltd.
    • 15.3.7.1 Company Overview
    • 15.3.7.2 Product Portfolio
  • 15.3.8 Johnson & Johnson
    • 15.3.8.1 Company Overview
    • 15.3.8.2 Product Portfolio
    • 15.3.8.3 Financials
    • 15.3.8.4 SWOT Analysis
  • 15.3.9 Luxica Pharma Inc.
    • 15.3.9.1 Company Overview
    • 15.3.9.2 Product Portfolio
  • 15.3.10 Procter & Gamble Company
    • 15.3.10.1 Company Overview
    • 15.3.10.2 Product Portfolio
    • 15.3.10.3 Financials
    • 15.3.10.4 SWOT Analysis
  • 15.3.11 Purdue Pharma L.P.
    • 15.3.11.1 Company Overview
    • 15.3.11.2 Product Portfolio